Retrobulbar Optic Neuritis Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma

Pembrolizumab is a monoclonal antibody with anti-tumor effects. Only a few reports have previously described retrobulbar optic neuritis induced by pembrolizumab. We herein report the case of a 63-year-old man with advanced lung adenocarcinoma who received cisplatin, pemetrexed, and pembrolizumab com...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawakado, Keita, Tamura, Tomoki, Nakanishi, Masamoto, Makimoto, Go, Kuyama, Shoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758449/
https://www.ncbi.nlm.nih.gov/pubmed/34148963
http://dx.doi.org/10.2169/internalmedicine.7425-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758449/
https://www.ncbi.nlm.nih.gov/pubmed/34148963
http://dx.doi.org/10.2169/internalmedicine.7425-21

Ejemplares similares